INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of DexCom, Inc. (DXCM) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm

Core Points - A shareholder class action lawsuit has been filed against DexCom, alleging that the company made materially false and misleading statements regarding the G6 and G7 devices [1] - The lawsuit claims that DexCom made unauthorized design changes to the G6 and G7, which compromised their reliability and presented health risks to users [1] - The allegations include overstated claims about the enhancements and functionality of the G7, as well as downplaying the severity of issues related to the devices [1] - The lawsuit suggests that these actions have exposed DexCom to increased regulatory scrutiny and potential legal, reputational, and financial harm [1] Legal Context - Shareholders who purchased DexCom shares between July 26, 2024, and September 17, 2025, and suffered significant losses are encouraged to discuss their legal rights [2] - The deadline for shareholders to request to be appointed as lead plaintiff in the case is December 26, 2025 [3] - Holzer & Holzer, LLC is representing shareholders in this litigation and has a history of recovering significant amounts for investors affected by corporate misconduct [3]